Unidad de Regeneración Neural, Unidad Funcional de Investigación de Enfermedades Crónicas, Instituto de Salud Carlos III (ISCIII), 28220, Majadahonda, Madrid, Spain,
Stem Cell Rev Rep. 2013 Oct;9(5):685-99. doi: 10.1007/s12015-013-9443-6.
Human neurological disorders such as Alzheimer's disease (AD), Parkinson's disease, stroke or spinal cord injury are caused by the loss of neurons and glial cells in the brain or spinal cord in the Central Nervous System (CNS). Stem cell technology has become an attractive option to investigate and treat these diseases. Several types of neurons and glial cells have successfully been generated from stem cells, which in some cases, have ameliorated some dysfunctions both in animal models of neurological disorders and in patients at clinical level. Stem cell-based therapies can be beneficial by acting through several mechanisms such as cell replacement, modulation of inflammation and trophic actions. Here we review recent and current remarkable clinical studies involving stem cell-based therapy for AD and stroke and provide an overview of the different types of stem cells available nowadays, their main properties and how they are developing as a possible therapy for neurological disorders.
人类神经系统疾病,如阿尔茨海默病(AD)、帕金森病、中风或脊髓损伤,是由中枢神经系统(CNS)中大脑或脊髓的神经元和神经胶质细胞的丧失引起的。干细胞技术已成为研究和治疗这些疾病的一种有吸引力的选择。已经成功地从干细胞中产生了几种类型的神经元和神经胶质细胞,在某些情况下,这些细胞在神经紊乱的动物模型和临床水平的患者中改善了一些功能障碍。基于干细胞的疗法可以通过多种机制发挥作用,如细胞替代、炎症调节和营养作用。在这里,我们回顾了最近和目前涉及 AD 和中风的基于干细胞的治疗的显著临床研究,并概述了当今可用的不同类型的干细胞、它们的主要特性以及它们作为治疗神经系统疾病的潜在疗法的发展情况。